Skip to main content
Erschienen in: BMC Infectious Diseases 1/2022

Open Access 01.12.2022 | COVID-19 | Research

Bacterial colonization of the upper airways of children positive and negative for SARS-CoV-2 during the COVID-19 pandemic

verfasst von: Vincentia Rizke Ciptaningtyas, Rebriarina Hapsari, Endang Sri Lestari, Helmia Farida, Quirijn de Mast, Marinus Isaäk de Jonge

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2022

Abstract

Background

Our understanding of the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on bacterial colonization in the children’s upper nasopharyngeal tract during the coronavirus infectious disease (COVID-19) pandemic is limited. This study aimed to determine whether there were any differences in bacterial colonization between asymptomatic children with or without a positive SARS-CoV-2 quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) results in the community setting.

Methods

A cross-sectional community-based exploratory study was conducted from March to May 2021 in Semarang, Central Java Province, Indonesia. Using stored nasopharyngeal swabs collected from children under 18 years as a contact tracing program, we performed a real-time quantitative (qPCR) for the most important bacterial colonizing pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Klebsiella pneumoniae.

Results

Swabs from a total of 440 children were included in this study, of which 228 (51.8%) were RT-qPCR-confirmed SARS-CoV-2 positive. In the 440 children, colonization rates were highest for H. influenzae (61.4%), followed by S. pneumoniae (17.5%), S. aureus (12.0%), and K. pneumoniae (1.8%). The co-occurrence of both S. pneumoniae and H. influenzae in the upper respiratory tract was significantly associated with a SARS-CoV-2 negative RT-qPCR. In contrast, colonization with only S. aureus was more common in SARS-CoV-2-positive children.

Conclusion

Overall, this exploratory study concludes that there is a significant difference in the bacterial nasopharyngeal colonization pattern between SARS-CoV-2 positive and negative in asymptomatic children in the community in Indonesia.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12879-022-07851-z.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that first emerged in late 2019 and has since caused a pandemic of coronavirus disease 2019 (COVID-19), which poses a threat to human health and public safety globally [1]. A variety of symptoms, ranging from mild to severe respiratory failure, indicate the pathophysiology of SARS-CoV-2 infection in people. SARS-CoV-2 replicates primarily in the epithelial cells of the upper respiratory tract, from where it spreads and penetrates the lungs [2]. However, as the body of knowledge about the continuing pandemic grows, it seems that young children are less vulnerable to severe symptoms of SARS-CoV-2 infection [3].
Several studies have been conducted to determine the existence of SARS-CoV-2 co-infection with respiratory bacteria in the majority of adult patients who have contracted the virus. Gram-negative bacilli: Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Staphyloccocus aureus were commonly found as hospital-acquired superinfections, while Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae were found as community-acquired co-infection [46].
S. pneumoniae, H. influenzae, S. aureus, and K. pneumoniae are significant colonizers of children’s upper respiratory tracts that lead to lower respiratory tract infections, the leading cause of death in children under five years [710]. S. pneumoniae and H. influenzae are the most common bacterial causes of pneumonia, with S. aureus and K. pneumoniae associated with certain severe cases [11]. K. pneumoniae, along with other Gram-negative bacilli, is a more prevalent cause of pneumonia in Asia than in other regions worldwide [10]. By systematically searching the literature, we found that K. pneumoniae was the most frequently reported bacterial agent of lower respiratory tract infection in children under the age of five in Indonesia [12].
There is very little information about the association between the SARS-CoV-2 virus and bacterial colonization in asymptomatic children during public health measures during the COVID-19 pandemic. Therefore, this exploratory research aimed to determine whether there were any differences in S. pneumoniae, H. influenzae, S. aureus, and K. pneumoniae colonization between asymptomatic children with positive and negative SARS-CoV-2 RT-qPCR results in the community setting in Indonesia.

Methods

Study design and setting

A cross-sectional community-based exploratory study was conducted from March to May 2021 in Semarang, Central Java Province, Indonesia.

Study population

The inclusion criteria in this study were the availability of nasopharyngeal swabs of children below the age of 18 years that were recently (less than two weeks before the visit) in contact with a confirmed COVID-19 patient from which swab samples were collected for contact tracing and were asymptomatic during the sample collection. We excluded swabs with an insufficient sample volume or incomplete personal data (date of birth, sex, national identification number). The Ethical Committee of the Faculty of Medicine Universitas Diponegoro approved the study protocol (No.64/EC/KEPK/FK-UNDIP/III/2021).

Clinical data collection

We extracted age and sex data from the patient registry in the laboratory information system.

Sample collection

The nasopharyngeal swabs were collected by trained nurses from Primary Health Centres (Puskesmas) in viral transport medium across Central Java and were sent to the Microbiology Laboratory, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia. This laboratory is the designated reference laboratory for SARS-CoV-2 PCR testing under standardized clinical laboratory conditions.
In order to provide a reliable comparison between SARS-CoV-2 positive and negative swab samples, we selected all positive samples together with a similar number of randomly selected negative samples from the same day. If the SARS-CoV-2 positive sample was higher than the number of negative samples on a respective day, all available negative samples were selected on that particular day. All samples were aliquoted (1 ml) and stored in a − 80 °C freezer until further analysis.

Quantitative real-time PCR (qPCR)

DNA for the positive controls was extracted from S. pneumoniae (ATCC® 49,619™), S. aureus (ATCC® 25,923™), K. pneumoniae (ATCC® 33,495™), and H. influenzae (ATCC® 49,247™) using PureLink™ Genomic DNA Mini Kit (cat.no.K182001, Invitrogen™, USA) based on the protocol for Gram-positive and Gram-negative bacteria. For real-time PCR standards, sequential dilution (tenfold) of the DNA spanning seven orders of magnitude starting at 10 ng/ µl was prepared in two sets on each plate to validate PCR efficiency across the sample.
Each sample was thawed, vortexed, and aliquoted (100 µl) into a microcentrifuge tube (cat.no 1210-SoS, SSIbio®, USA). The aliquoted samples were incubated at 95 °C for 15 min to lyse the bacteria and extract their DNA. Based on previous studies, four sets of primers (Table 1) based on highly conserved gene-specific for each bacterium were used [1316]. The PCR was all performed using RealQ Plus 2 × Master Mix for Probe without ROX™ (cat.no.A313402, Ampliqon, Denmark) two-step PCR program in CFX Connect™ Real-Time PCR Detection System (Bio-Rad, USA). The PCR was done in a 25 µl reaction containing 1 µl of template DNA. Cycling conditions were 95 °C for 15 min, followed by 49 cycles of 95 °C for 15 s, and 20 s at 61 °C for S. pneumoniae and K. pneumoniae, 60 °C for S. aureus, and 55 °C for H. influenzae, respectively. Samples in which the quantification cycle (Cq) values < 40 were measured were considered positive.
Table 1
Primers and probes used for the qPCR assays to detect S. pneumoniae, H. influenzae, S. aureus, and K. pneumoniae
Organism (target gene)
Primer name
Nucleotide sequence of primers and probes
S. pneumoniae (lytA)
lytA-CDC-f
5ʹ-ACGCAATCTAGCAGATGAAGCA-3ʹ
lytA-CDC-r
5ʹ-TCGTGCGTTTTAATTCCAGCT-3ʹ
lytA-CDC-pr
5ʹ-FAM-GCCGAAAACGCTTGATACAG GGAG-3ʹ- BHQ1
S. aureus (nuc)
nucF
5ʹ-GTTGCTTAGTGTTAACTTTAGTTGTA-3ʹ
nucR
5ʹ-AATGTCGCAGGTTCTTTATGTAATTT-3ʹ
nucPr
5ʹ-FAM-AAGTCTAAGTAGCTCAGCAAATGCA-3ʹ- BHQ1
K. pneumoniae (mdh)
mdhF
5ʹ-CGGGCGTAGCGCGTAA-3ʹ
mdhR
5ʹ-GATACCCGCATTCACATTAAACAG-3ʹ
mdhP
5ʹ-FAM-CCCGGCATGGATCGTTCCGA-3ʹ-BHQ1
H. influenzae (hpd)
hpdF729
5ʹ-AGATTGGAAAGAAACACAAGAAAAAGA-3ʹ
 
hpdR819
5ʹ-CACCATCGGCATATTTAACCACT-3ʹ
 
hpdPbr762i
5ʹ-FAM-AAACATCCAATCGT-BHQ1-AATTATAGTTTACCCAATAACCC-3ʹ- C6

Statistical analysis

We computed the Mann–Whitney U test to determine the statistical difference in the median age between those that tested positive and negative for COVID-19. Using Pearson’s chi-square tests or Fisher’s exact test, we compared age groups and sex between SARS-CoV-2 infected and uninfected children; bacterial species identified in children of different age groups, and co-colonization of bacterial species in children tested positive and negative for COVID-19. To determine the statistically significant differences in the mean rank of the Cq value among four bacteria, we used the Kruskal–Wallis H test. The effect size of the association between two nominal variables (bacteria-virus co-occurrence) was determined using Odds Ratio (95% confidence interval (CI)). All tests were performed on a two-tail hypothesis, and a p value below 0.05 was considered statistically significant. All data collected were analysed using SPSS® Version 26.0 (IBM Corp. Release 2019. IBM® SPSS® Statistics for Macintosh, Version 26.0. Armonk, NY).

Results

Demographic characteristic

A total of 440 samples from healthy and asymptomatic children were collected in this study. Two hundred twenty-eight (51.8%) children had SARS-CoV-2 positive RT-qPCR results. The majority were children aged twelve to seventeen (50.5%) and females (50.9%). The median (IQR) age of the children with positive or negative SARS-CoV-2 RT-qPCR results was 12 (7) and 11(8) years, respectively. A marginally significant association was found for SARS-CoV-2 positivity within the age group (p = 0.055), and no statistically significant association was found for SARS-CoV-2 positivity within gender (p = 0.44) (Table 2).
Table 2
Demographic characteristics of the study participants
 
SARS-CoV-2 negative (N = 212)
n (%)
SARS-CoV-2 positive (N = 228)
n (%)
p
Age (median; IQR)
12; 7
11; 8
0.023*
Age groups (years)
  
0.055+
 0–5
49 (23.1)
35 (15.4)
 
 6–11
67 (31.6)
67 (29.4)
 
 12–17
96 (45.3)
126 (55.3)
 
Sex
   
 Male
100 (47.2)
116 (50.9)
0.44
 Female
112 (52.8)
112 (49.1)
 
*Variables analysed using the Mann–Whitney U test, p < 0.05
+Variables analysed using Pearson’s chi-square test, marginally significant

Bacterial colonization in the upper respiratory tract

The Cq values from all samples, indicative of the density of bacterial colonization, were determined for S. aureus, S. pneumoniae, K. pneumoniae, and H. influenzae (Fig. 1). S. pneumoniae had the lowest Cq value median (33.4), followed by H. influenzae (35.9), S. aureus (36.9), and K. pneumoniae (38.0) (p < 0.001). H. influenzae had the highest colonization rate (61.4%), followed by S. pneumoniae (17.5%), S. aureus (12.0%), and K. pneumoniae (1.8%) (Table 3). There was a significant association between age and overall colonization with S. aureus (p = 0.003) and S. pneumoniae (p = 0.003), with the highest colonization rates in 6–11 years (Table 3).
Table 3
Comparison of SARS-CoV-2 and bacterial species identified in children of different age groups
 
Age 0–5 years
(N = 84)
n (%)
Age 6–11 years
(N = 134)
n (%)
Age 12–17 years
(N = 222)
n (%)
p
SARS-CoV-2
35 (15.4)
67 (29.4)
126 (55.3)
0.055+
S. aureus
7 (13.2)
27 (50.9)
19 (35.8)
0.003*
S. pneumoniae
12 (15.6)
36 (46.8)
29 (37.7)
0.003*
K. pneumoniae
2 (25.0)
2 (25.0)
4 (50.0)
0.80†
H. influenzae
53 (19.6)
83 (30.7)
134 (49.6)
0.89
The number for each bacterial species represents overall detection (regardless of the bacteria as a single colonizer or in the co-colonization state with other bacteria)
+Variables analysed using Pearson’s chi-square test, marginally significant
*Variables analysed using Pearson’s chi-square test, p < 0.05
†Variable analysed using Fisher’s exact test

Co-colonization of bacterial species in the upper respiratory tract

Table 4 summarizes the colonization prevalence in children positive or negative for SARS-CoV-2. In most nasopharyngeal swab samples, only a single species was detected (Table 4). Although H. influenzae had the highest detection rate in children, those who were only colonized with S. aureus had higher odds of being SARS-CoV-2 positive (OR 3.9, 95% CI 1.1 to 13.9). In this population, co-occurrence of S. pneumoniae and H. influenzae dominates (61.5%) the other two bacterial species combinations. More importantly, this specific combination was significantly associated with SARS-CoV-2 negative RT-qPCR results (OR 0.5, 95% CI 0.3 to 0.9).
Table 4
Co-colonization of bacterial species in SARS-CoV-2 infected and uninfected children
 
SARS-CoV-2 negative
(N = 212)
n (%)
SARS-CoV-2 positive
(N = 228)
n (%)
Odd ratio
(95% CI)
No colonization
70 (33.0)
70 (30.7)
0.9 (0.6 to 1.3)
Single bacterial species
90 (42.5)
108 (47.4)
 
 S. aureus
3 (3.3)
12 (11.1)
3.8 (1.1 to 13.9)*
 S. pneumoniae
4 (4.4)
7 (6.5)
1.6 (0.5 to 5.7)
 K. pneumoniae
2 (2.2)
0 (0.0)
NA
 H. influenzae
81 (90.0)
89 (82.4)
1.0 (0.7 to 1.5)
Two bacterial species
50 (23.6)
46 (20.2)
 
 S. aureus and S. pneumoniae
0 (0.0)
2 (4.3)
NA
 S. aureus and H. influenzae
10 (20.0)
20 (43.5)
1.9 (0.9 to 4.3)
 S. pneumoniae and H. influenzae
37 (74.0)
22 (47.8)
0.5 (0.3 to 0.9)*
 K. pneumoniae and H. influenzae
3 (6.0)
2 (4.3)
0.6 (0.1 to 3.7)
Three bacterial species
2 (0.9)
4 (1.8)
 
 S. aureus and S. pneumoniae and H. influenzae
2 (100.0)
3 (75.0)
1.4 (0.2 to 8.5)
 S. aureus and K. pneumoniae and H. influenzae
0 (0.0)
1 (25.0)
NA
NA  not applicable, CI  confidence interval
*Variables analysed using Pearson’s chi-square test, p < 0.05

Discussion

This study was conducted during the second wave of the COVID-19 pandemic, when the delta variant was most prevalent [17] in Indonesia, to determine any differences in the colonization patterns of S. pneumoniae, H. influenzae, S. aureus, and K. pneumoniae between SARS-CoV-2 positive and negative children. In this study, it was found that H. influenzae had the highest colonization rate. Interestingly, co-colonization of S. pneumoniae and H. influenzae in the nasopharynx was associated with the absence of SARS-CoV-2 infection, while children only colonized with S. aureus had higher odds of having SARS-CoV-2 positive results. These results suggest a difference in bacterial colonization patterns between SARS-CoV-2 RT-qPCR positive and negative in asymptomatic children.
In this study, we found that from all 440 children included, H. influenzae had the highest colonization rate, followed by S. pneumoniae, S. aureus, and K. pneumoniae. This result differs from pre-COVID-19 studies, which found the highest colonization rates for S. pneumoniae, followed by H. influenzae and S. aureus [12]. A pre-COVID-19 study among HIV-infected children in Jakarta and healthy children in three provinces in Indonesia (West Java, West Nusa Tenggara, West Sumatra) showed 18% and 27,5% H. influenzae carrier rates [18, 19]. Compared to other Southeast Asia countries, the colonization rate of H. influenzae in our study is also considerably higher. A study in Malaysia showed 14,3% and 4,9% H. influenzae carrier rates in healthy unvaccinated and vaccinated children, respectively [20]. The Indonesian ministry of health started to include the Hib vaccination in the national vaccination program in 2013; this might have caused the higher carrier rate of H. influenzae in this study since most of our participants were older than 5 years old.
While an earlier study suggested that bacterial co-infection with H. influenzae, S. pneumoniae, increased the risk of morbidity and mortality in patients hospitalized due to community-acquired pneumoniae and SARS-CoV-2 infection [21, 22], we found that this specific combination of pathogenic bacterial species was associated with reduced occurrence of SARS-CoV-2 infection in children. Co-occurrence of H. influenzae and S. pneumoniae, leading to increased density of H. influenzae in the presence of S. pneumoniae in a neonatal rat model, was previously shown and suggested synergy between these species [23]. A possible explanation is a nutritional dependency in which S. pneumoniae provides nutrients to H. influenzae, as observed for S. aureus and H. influenzae, described as the ‘satellite phenomenon’ [23]. It is tempting to speculate that this synergistic interaction in the nasopharynx elicits mucosal immune responses leading to inhibition of infection with SARS-CoV-2, although a causal link has not been demonstrated in this study.
The association of SARS-CoV-2 infection and S. aureus colonization, as found in this study, is in line with other studies [22] showing that although bacterial co-infection in COVID-19 patients was low, S. aureus was the most commonly found species. Regarding K. pneumoniae, we found 1.8% carriage in all samples. This result is lower than a study held eight years ago in Indonesia that found 7% of K. pneumoniae carriage in children under five years of age [24]. However, as proposed by Farida and colleagues, exposure to unsafe food and water was likely the culprit of the previously high carrier rate [24]; during mobility reduction and school closure, children were less exposed to street food, thus reducing the change of K. pneumoniae transmission in the pandemic era.
We acknowledge some limitations in this study. First, we had no access to information on the history of the children’s vaccination and current antibiotic use; thus, we cannot compare the bacterial colonization among children who have received a vaccination and have used antibiotics and those who have not. Second, there is no exact data related to when the children were exposed to SARS-CoV-2 infection. Despite these limitations, to our knowledge, this is the first study to examine the differences in bacterial colonization between SARS-CoV-2 RT-qPCR positive and negative in asymptomatic children. Further studies using 16 s rRNA sequencing and metagenomics in both symptomatic and asymptomatic children would improve our understanding of global changes in the microbiome of the upper respiratory as a consequence of SARS-CoV-2 infection.

Conclusion

This explorative study shows differences in the bacterial nasopharyngeal colonization pattern between asymptomatic SARS-CoV-2 positive and negative children during public health measures in the community in Indonesia. Differences in the colonization pattern might influence the epidemiology of bacterial respiratory tract infections in children, as well as modulate the risk for SARS-CoV-2 infection.

Acknowledgements

We thank Scott Maurits from the Department for Health Evidence, Radboudumc, Nijmegen, the Netherlands, for his statistical support and Christa van der Gaast-de Jongh from the Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands, for her excellent technical support.

Declarations

The research was performed in accordance with the Declaration of Helsinki. Data were collected for the purpose of public health response, and therefore, informed consent was not obtained. Informed consent was waived by the Ethical Committee of the Faculty of Medicine Universitas Diponegoro (No.64/EC/KEPK/FK-UNDIP/III/2021). The dataset used for this research was de‐identified. The Ethical Committee of the Faculty of Medicine Universitas Diponegoro approved the study protocol (No.64/EC/KEPK/FK-UNDIP/III/2021).
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Literatur
1.
Zurück zum Zitat Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–54.CrossRefPubMed Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–54.CrossRefPubMed
2.
Zurück zum Zitat Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465–9.CrossRefPubMed Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465–9.CrossRefPubMed
3.
Zurück zum Zitat Bhuiyan MU, Stiboy E, Hassan MZ, Chan M, Islam MS, Haider N, et al. Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis. Vaccine. 2021;39(4):667–77.CrossRefPubMed Bhuiyan MU, Stiboy E, Hassan MZ, Chan M, Islam MS, Haider N, et al. Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis. Vaccine. 2021;39(4):667–77.CrossRefPubMed
4.
Zurück zum Zitat Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–9.CrossRefPubMedPubMedCentral Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–9.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–68.PubMed Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–68.PubMed
6.
Zurück zum Zitat Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–8.CrossRefPubMed Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–8.CrossRefPubMed
7.
8.
Zurück zum Zitat Giufre M, Daprai L, Cardines R, Bernaschi P, Rava L, Accogli M, et al. Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. Vaccine. 2015;33(46):6227–34.CrossRefPubMed Giufre M, Daprai L, Cardines R, Bernaschi P, Rava L, Accogli M, et al. Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. Vaccine. 2015;33(46):6227–34.CrossRefPubMed
9.
Zurück zum Zitat Grousd JA, Rich HE, Alcorn JF. Host-pathogen interactions in gram-positive bacterial pneumonia. Clin Microbiol Rev. 2019;32(3). Grousd JA, Rich HE, Alcorn JF. Host-pathogen interactions in gram-positive bacterial pneumonia. Clin Microbiol Rev. 2019;32(3).
10.
Zurück zum Zitat Juan CH, Fang SY, Chou CH, Tsai TY, Lin YT. Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study. Antimicrob Resist Infect Control. 2020;9(1):4.CrossRefPubMedPubMedCentral Juan CH, Fang SY, Chou CH, Tsai TY, Lin YT. Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study. Antimicrob Resist Infect Control. 2020;9(1):4.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ciptaningtyas VR, De Mast Q, De Jonge MI. The burden and etiology of lower respiratory tract infections in children under five years of age in Indonesia. J Infect Dev Ctries. 2021;15(5):603–14.CrossRefPubMed Ciptaningtyas VR, De Mast Q, De Jonge MI. The burden and etiology of lower respiratory tract infections in children under five years of age in Indonesia. J Infect Dev Ctries. 2021;15(5):603–14.CrossRefPubMed
13.
Zurück zum Zitat Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45(8):2460–6.CrossRefPubMed Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45(8):2460–6.CrossRefPubMed
14.
Zurück zum Zitat Wang X, Mair R, Hatcher C, Theodore MJ, Edmond K, Wu HM, et al. Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. Int J Med Microbiol. 2011;301(4):303–9.CrossRefPubMed Wang X, Mair R, Hatcher C, Theodore MJ, Edmond K, Wu HM, et al. Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. Int J Med Microbiol. 2011;301(4):303–9.CrossRefPubMed
15.
Zurück zum Zitat Kilic A, Muldrew KL, Tang YW, Basustaoglu AC. Triplex real-time polymerase chain reaction assay for simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci and determination of methicillin resistance directly from positive blood culture bottles. Diagn Microbiol Infect Dis. 2010;66(4):349–55.CrossRefPubMed Kilic A, Muldrew KL, Tang YW, Basustaoglu AC. Triplex real-time polymerase chain reaction assay for simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci and determination of methicillin resistance directly from positive blood culture bottles. Diagn Microbiol Infect Dis. 2010;66(4):349–55.CrossRefPubMed
16.
Zurück zum Zitat Fukumoto H, Sato Y, Hasegawa H, Saeki H, Katano H. Development of a new real-time PCR system for simultaneous detection of bacteria and fungi in pathological samples. Int J Clin Exp Pathol. 2015;8(11):15479–88.PubMedPubMedCentral Fukumoto H, Sato Y, Hasegawa H, Saeki H, Katano H. Development of a new real-time PCR system for simultaneous detection of bacteria and fungi in pathological samples. Int J Clin Exp Pathol. 2015;8(11):15479–88.PubMedPubMedCentral
18.
Zurück zum Zitat Dunne EM, Murad C, Sudigdoadi S, Fadlyana E, Tarigan R, Indriyani SAK, et al. Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: a cross-sectional study. PLoS ONE. 2018;13(4): e0195098.CrossRefPubMedPubMedCentral Dunne EM, Murad C, Sudigdoadi S, Fadlyana E, Tarigan R, Indriyani SAK, et al. Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: a cross-sectional study. PLoS ONE. 2018;13(4): e0195098.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Safari D, Lestari AN, Khoeri MM, Tafroji W, Giri-Rachman EA, Harimurti K, et al. Nasopharyngeal carriage and antimicrobial susceptibility profile of Haemophilus influenzae among patients infected with HIV in Jakarta, Indonesia. Access Microbiol. 2020;2(12): acmi000165.CrossRefPubMedPubMedCentral Safari D, Lestari AN, Khoeri MM, Tafroji W, Giri-Rachman EA, Harimurti K, et al. Nasopharyngeal carriage and antimicrobial susceptibility profile of Haemophilus influenzae among patients infected with HIV in Jakarta, Indonesia. Access Microbiol. 2020;2(12): acmi000165.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Palaniappan PA, Mohamed Sukur S, Liow YL, Maniam S, Sherina F, Ahmad N. Carriage of Haemophilus influenzae among children attending childcare centres in Kuala Lumpur, Malaysia in the post vaccination era: a cross-sectional study. Vaccine. 2020;38(51):8232–7.CrossRefPubMed Palaniappan PA, Mohamed Sukur S, Liow YL, Maniam S, Sherina F, Ahmad N. Carriage of Haemophilus influenzae among children attending childcare centres in Kuala Lumpur, Malaysia in the post vaccination era: a cross-sectional study. Vaccine. 2020;38(51):8232–7.CrossRefPubMed
21.
Zurück zum Zitat Ngocho JS, Minja L, van der Gaast-de Jongh CE, Rahamat-Langendoen JC, Langereis JD, Mmbaga BT, et al. Viral-bacterial (co-) occurrence in the upper airways and the risk of childhood pneumonia in resource-limited settings. J Infect. 2020;81(2):213–20.CrossRefPubMedPubMedCentral Ngocho JS, Minja L, van der Gaast-de Jongh CE, Rahamat-Langendoen JC, Langereis JD, Mmbaga BT, et al. Viral-bacterial (co-) occurrence in the upper airways and the risk of childhood pneumonia in resource-limited settings. J Infect. 2020;81(2):213–20.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Margolis E, Yates A, Levin BR. The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host’s immune response. BMC Microbiol. 2010;10:59.CrossRefPubMedPubMedCentral Margolis E, Yates A, Levin BR. The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host’s immune response. BMC Microbiol. 2010;10:59.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Farida H, Severin JA, Gasem MH, Keuter M, van den Broek P, Hermans PW, et al. Nasopharyngeal carriage of Klebsiella pneumoniae and other Gram-negative bacilli in pneumonia-prone age groups in Semarang, Indonesia. J Clin Microbiol. 2013;51(5):1614–6.CrossRefPubMedPubMedCentral Farida H, Severin JA, Gasem MH, Keuter M, van den Broek P, Hermans PW, et al. Nasopharyngeal carriage of Klebsiella pneumoniae and other Gram-negative bacilli in pneumonia-prone age groups in Semarang, Indonesia. J Clin Microbiol. 2013;51(5):1614–6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Bacterial colonization of the upper airways of children positive and negative for SARS-CoV-2 during the COVID-19 pandemic
verfasst von
Vincentia Rizke Ciptaningtyas
Rebriarina Hapsari
Endang Sri Lestari
Helmia Farida
Quirijn de Mast
Marinus Isaäk de Jonge
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2022
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07851-z

Weitere Artikel der Ausgabe 1/2022

BMC Infectious Diseases 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.